维普中文期刊产品整合服务
38篇 您的检索式:作者名="Pignot G"
    题名 作者 年代 出处 被引量
1Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transi- tional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker显示文摘Pignot G Bieche I Vacher S 2009Eur Urol2009,56,4:1
2Comparison of on- cological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract= results from a large French multicentre study显示文摘COLIN P OUZZANE A PIGNOT G 2012BJU Int2012,11,:1
3Survival analysis of130 patients with papillary renal cell carcinoma : prog-nostic utility of type 1 and type 2 subclassification显示文摘Pignot G Elie C Conquy S 2007Urology2007,69,2:1
4Comparison oI ontological outcomes after segmental uretereetomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results {rom a large French multicentre study显示文摘Colin P Ouzzane A Pignot G 2012BJLT Int2012,110,8:1
5Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract:results from a large French multicentre study显示文摘Colin P Ouzzane A Pignot G 2012BJU Int2012,110,8:1
6Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentrestudy显示文摘Colin P Ouzzane A Pignot G 2012BJUInt2012,110,8:1
7Hedgehog pathway activa- tion in human transitional cell carcinoma of the bladder 显示文摘Pignot G Vieillefond A Vacher S 2012Br J Cancer2012,106,6:1
8Survival analysis of 130 patients with papillary renal cell carcinoma:prognostic utility of type 1 and type 2 subclassification显示文摘Pignot G Elie C Conquy S 0,,02:1
9Survival analysis of 130patients with papillary renal cell carcinoma:prognostic utility of type 1and type 2subclassification显示文摘Pignot G Elie C Conquy S 2007Urology2007,69,2:1
10Laparoscopic partialnephrectomy: is it worth still performing the retroperitonealroute-显示文摘Ouzaid I Xylinas E Pignot G 2012Adv Urol2012,2012,:1
11Laparoscopic partial nephrectomy:is it worth still performing the retroperitoneal route显示文摘OUZAID I XYLINAS E PIGNOT G 0,,:1
12Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study 显示文摘Colin P Ouzzane A Pignot G 2012BJU Int2012,110,8:1
13Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification 显示文摘Pignot G Elie C Conquy S 2007Urology2007,69,2:1
14Survival analysis of 130 patients with papillary renal cell carcinoma : prognostic utility of type 1 and type 2 subelassification显示文摘Pignot G Elie C Conquy S 2007Urology2007,69,:1
15MicroRNA expres- sion profile in a large series of bladder tumors: Identification of a 3-miRNA signature associated with aggressiveness of muscle-in- vasive bladder cancer 显示文摘Pignot G Cizeron-Clairac G Vacher S 2013Int J Cancer2013,132,11:1
16Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterecto- my in urothelial carcinomas of the upper urinary tract : results from a large French multicentre study 显示文摘Colin P Ouzzane A Pignot G 2012BJU Int2012,110,8:1
17Survival analysis of 130 patients with papillary renal cell carcinoma:prognostic utility of type 1 and type 2 subclassification显示文摘Pignot G Elie C Conquy S 2007Urology2007,69,2:1
18Survival analysis of 130 patients with papillary renal cell carcinoma =prognostic utility of type 1 and type 2 subclassification显示文摘Pignot G Elie C Conquy S 2007Urology2007,69,2:1
19microRNA expression profile in a large series of bladder tumors : identification of a 3- miRNA signature associated with aggressiveness of muscle - inva- sive bladder cancer显示文摘Pignot G Cizeron-Clairac G Vacher S 2013Int J Cancer2013,132,11:1
20Hedgehog pathway activa- tion in human transitional cell carcinoma of the bladder显示文摘Pignot G Vieillefond A Vacher S 2012Br J Cancer2012,106,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费